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Abstract
Background and aims External support of vein grafts by
fibrin glue possibly prevents overdistension, vascular
remodeling, and neointimal hyperplasia. Previous animal
models of neointimal hyperplasia showed conflicting
results. Here, long-term effects of external fibrin glue
support were studied in a new rat model of jugular vein
to abdominal aorta transposition.
Materials and methods and methods In male Wistar rats
(250–300 g) right jugular vein (1.0–1.5 cm) was transposed
to the infrarenal aorta. Fibrin glue (0.25 ml) covered the
vein before releasing the vascular clamps (n=6). Control
vein grafts were exposed directly to blood pressure. After
16 weeks vein grafts were pressure-fixed for histology.
Intima thickness, luminal and intimal area were measured
by planimetry and elastic fibers demonstrated by Elastica
van Giesson staining.
Results Intimal thickness (74.04±6.7 µm vs 1245±187 µm,
control vs fibrin treatment; p<0.001), intimal area (2517.16±
355 mm2 vs 18424±4927 mm2, control vs fibrin treatment;
p<0.05) and luminal area (2184.75±347 mm2 vs 7231.85±
1782 mm2, control vs fibrin treatment; p<0.05) were
significantly increased, elastic fibers in the vessel wall were
diminished and the vessel wall infiltrated by mononuclear
cells in fibrin glue supported veins.
Conclusion External support of vein grafts by fibrin glue
leads to aneurysmal degeneration and intimal hyperplasia,
thereby possibly jeopardizing long-term graft patency.
Keywords Fibrin support . Vein graft failure .
Neointima formation
Introduction
Vein grafts for bypass grafting in vascular and cardiovas-
cular surgery exert good long-term patency and show far
better patency rates than synthetic grafts in peripheral
vascular surgery [1]. However, after 10 years 40% of vein
grafts in coronary artery surgery [2] and 50% of peripheral
venous grafts fail, mainly due to the development of
neointimal hyperplasia, especially at sites of anastomosis
[3]. Vein graft damage after implantation is believed to be
due to arterial pressure, thereby increasing wall tension,
shear stress and pulsatile blood flow. This ultimately leads
to overdistension of the vein graft promoting intimal
hyperplasia through a remodeling process, which involves
proliferation and migration of vascular smooth muscle cells
(VSMC) as well as myofibroblast to the vein graft [4]. To
reduce wall shear stress and to prevent the proposed
negative effects of early vein graft distension due to arterial
pressure, several ‘extra vascular support’ strategies have
been introduced. These include the placement of a porous,
non-restrictive, polyester stent [5–7], or a bio absorbable
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sheath [8] or the use of perivenous application of fibrin glue
[9]. Perivenous fibrin glue has been used in a variety of
experimental models and for different follow-up times [10–
12]. The results of these studies were conflicting in terms of
the development of intimal hyperplasia at different time
points. Because endpoints were relatively early after venous
grafting we sought to test longer follow-up times in a new




Male Wistar rats, body weight 250–350 g, were purchased
from Charles River Laboratories (Sulzfeld, Germany). Rats
were fed standard laboratory chow and were kept according
to the German legislation on the protection of animals at a
12-h day-and-night shift. The protocol was approved by the
local authorities on the protection of animals (Niedersäch-
sisches Landesamt für Verbraucherschutz und Lebensmit-
telsicherheit/Tierschutz, AZ: 33.42502–046/06, 29.06.06).
Operative procedure
This model has been used in mice, but has not been
described in rats and offers a complete arterialized graft
exposed to the arterial blood pressure [13].
After Sevoflurane anesthesia, right jugular vein was
freed from surrounding tissue and small vein branches. It
was then harvested at a length of 1.0–1.5 cm. The vein was
flushed gently free from blood with 4°C Ringer solution
with a syringe and stored in cold Ringer solution until
implantation. Then the abdominal aorta was separated from
the infrarenal cava vein. A corresponding segment of 1-cm
aorta was excised and the jugular vein interposed with
interrupted 8-0 nylon sutures.
Experimental design
N=6 animals each were assigned to the following groups:
Fibrin group Before declamping 0.25 ml of Fibrin glue
(Tissucol Duo S 0.5 ml Immuno, Baxter Deutschland
GmbH Edisonstraße 4 85716 Unterschleißheim, Germany)
was applied onto the transposed vein graft. Then the blood
flow was restored. Animals were followed for 16 weeks
and killed thereafter.
Control group Blood flow was restored without application
of Fibrin glue. Animals were followed as described for the
Fibrin group.
Fibrin control group: the jugular vein was freed as for
transposition but left in place and covered with 0.25 ml of
Fibrin glue (Tissucol Duo S 0.5 ml Immuno, Baxter
Deutschland GmbH Edisonstraße 4 85716 Unterschleißheim,
Germany)
Histology and morphometry
The vein segment was pressure fixated for 15 min with 4%
Phosphate buffered Formalin at a hydrostatic pressure of
100 mmHg by flushing the formalin through the abdominal
aorta replacing the entire blood volume by formalin. The
probes were then stored for 36 h in formalin. For wax
embedding, three segments were removed from each vein
graft, dehydrated, and embedded in paraffin wax with their
axis perpendicular to the cutting plane. Sections were
stained with hematoxylin and eosin and elastic van Gieson
for examination under light microscopy.
Each segment was analyzed in a blinded fashion. Vessel
wall dimensions, intimal and luminal areas were measured
by computer-aided planimetry with use of an Olympus®
BH-2 microscope video camera, head (JVC TK-870E),
computer (Victor V386A, Victor Technologies), Softa-
Olympus DP-Soft 3.1® software and image-analysis system
(Olympus Europe Holding GmbH, Hamburg, Germany).
The area enclosed by the endothelium defined the lumen.
The area enclosed between the internal elastic lamina and
the lumen defined the intima. Measurements of perimeters
of the lumen, intimal thickness, and total wall thickness
were obtained. Mean values of luminal and intimal circum-
ferences, as well as intimal and total wall thickness, were
then calculated for all sections from the same graft.
Statistics
All values are presented as mean ± standard error of the
mean (SEM). Data were analyzed for statistical difference
by aid of the computer software GraphPad Instat® Version
3.05. Non-parametric statistic test Mann–Whitney was used
to detect statistical differences. A two-tailed p value<0.05
was accepted statistically significant.
Results
Morphology
Fibrin supported vessels showed a dense infiltration of
mononuclear cells and foam cells and a disruption of vessel
architecture. Neointimal formation was demonstrated in
both groups, but fibrin glue supported veins showed an
excessive formation of neointima and aneurysmal degener-
ation in four of six animals (Fig. 3A–C). Control vessels, in
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comparison, showed a preserved vessel architecture with no
or minimal infiltration of mononuclear cells and much less
development of intimal hyperplasia (Fig. 3D, E). Analyzing
the fibrin control group without transposition revealed a
damage in vessel wall architecture showing a scattered
appearance with some degree of inflammation (Fig 3F)
Luminal area
Analyzing the total luminal area by computer-aided
planimetry showed a significant increase in the fibrin-
treated group with aneurysmal degeneration in four of six
animals, 2,184.75±347 mm2 vs 7,231.85±1782 mm2,
control vs fibrin treatment; p<0.05 (Fig. 1, first column).
Intimal area
In addition to the increase of luminal area, the intima
showed a significant increase in the intimal area measured
in the fibrin groups compared to control, which also
showed development of neointima, 2,517.16±356 mm2 vs
18,424±4,927 mm2, control vs fibrin treatment; p<0.05,
(Fig. 1, second column).
Total wall thickness
Parallel to the increase in luminal area, the total wall thickness
in the fibrin-supported veins showed a significant increase in
thickness compared to control, 273±24 μm vs1,708±211 μm
control vs fibrin treatment; p<0.05, (Fig. 2A).
Intimal thickness
Corresponding to the increase in total wall thickness and
increase in intimal area, the intima thickened significantly in
fibrin-supported veins compared to control grafts with a lesser
degree of neointimal proliferation 74.04±6.7 μm vs 1245±
187 μm control vs fibrin treatment; p<0.05 (Fig. 2B).
Elastin fibers
Macroscopically, the elastin fibers in fibrin-supported veins
were strongly diminished compared to control and foam cells
were present only in fibrin-treated veins (Fig. 4). In the fibrin
control group without transposition, elastic fibers were
disrupted, causing loss of continuity within the vessel wall
(Fig. 4C).
Fig. 1 Planimetry of luminal area (µm2), enclosed by the endothelium
and intimal area, which is defined as the area enclosed between the
internal elastic lamina and the lumen. Control grafts (black columns)
without external support vs fibrin glue (white columns) externally



























Fig. 2 A total wall thickness (µm) measured in unsupported control
grafts (white columns) and fibrin glue externally supported grafts
(black columns). p<0.001 significant difference between the respec-
tive groups. B Intima thickness (µm) measured in unsupported control
grafts (white columns) and fibrin glue externally supported grafts
(black columns). p<0.001 significant difference between the respective
groups
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Discussion
Vein graft failure due to intimal hyperplasia jeopardizes long-
term patency of vein grafts in peripheral vascular and
cardiovascular surgery. Early graft damage is believed to be
due to surgical trauma and overdistension-inducing mecha-
nisms, which ultimately lead to intimal hyperplasia. There-
fore, protecting vein grafts from early pressure-related
distension injury is considered an important step toward
longer vein graft function. External fibrin glue support could
possibly counteract the intravenous arterial pressure thereby
possibly preventing early vein graft overdistension. On the
other hand, fibrin application could be used as a vehicle to
transport therapeutic agents to prevent intimal hyperplasia at
the site of action [14].
In a pig model of neointimal hyperplasia following
balloon angioplasty-related endothelial injury, local appli-
cation of losartan, an inhibitor of the renin–angiotensin
system, could reduce neointimal hyperplasia [14]. Howev-






Fig. 3 A Histological section stained by hematoxylin and eosin
showing a cross-section through the vein graft externally supported by
fibrin glue with intense neointimal formation (×25 magnification). B
Histological section stained by hematoxylin and eosin of a cross-
section through the vein graft externally supported by fibrin glue
showing adventitial destruction of an aneurysmatically degenerated
vein graft (×25 magnification) C Detailed view of a histological
section stained by hematoxylin and eosin of the vessel wall of a fibrin
glue externally supported vein graft showing dense infiltration of
mononuclear cells and foam cells (arrows) (×100 magnification) D
Histological section stained by hematoxylin and eosin of a cross-
section through an unsupported control vein graft showing a normal
appearance without adventitial destruction, aneurysmal degeneration
but intimal hyperplasia (×6.5 magnifications) E Histological section
stained by hematoxylin and eosin of a cross-section through an
unsupported control vein graft with a more detailed view on intimal
hyperplasia (×25 magnifications) F Histological section stained by
hematoxylin and eosin of a cross-section through a fibrin control vein
graft not transposed showing a disrupted vessel wall architecture (×25
magnifications)
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necessarily be applied to our vein graft model because of
the different pathophysiological cause, local endothelial
damage due to balloon inflation vs generalized intraluminal
pressure increase due to arterialization. Furthermore, the
different histologies of the vessel wall between arteries and
vein grafts (Figs. 3 and 4) may lead to different fibrin glue
concentrations within the vessel wall compartments and
may exert different effects. Previous in vitro experiments
have revealed that early distension could be diminished by
external fibrin glue support [7, 9, 11] and in vivo experi-
ments have furthermore revealed that perivenous support of
vein grafts with fibrin glue can attenuate the severe injury
encountered in the non-supported vein grafts exposed to
arterial pressure at early time points after grafting [10].
However, at later time points it was demonstrated that
external fibrin support showed negative or even detrimental
effects on vein grafts [12]. In the experiments reported here,
we could demonstrate a negative effect of external vein
graft support in the rat. We used a new rat model of jugular
vein transposition, which displayed a neointimal formation
at 16 weeks follow-up. In our hands, external fibrin support
leads to aneurysmal degeneration, excessive neointimal
formation, and to an inflammatory response with the
detection of foam cells and loss of elastin fibers. Control
grafts also showed neointimal formation but without
disruption of vessel wall architecture or aneurysmal
degeneration.
In the fibrin control group without transposition, a
similar disruption of elastic fibers within the vein graft
was noted pointing toward a detrimental effect of fibrin on
vessel wall architecture. This is in conjunction to previous
reports in a pig model [12] showing an interspecies
reproducible effect. It was stated that inflammation and
infiltration of macrophages to vascular tissue is associated
with fibrin [15]. As we could demonstrate the appearance
of foam cells in fibrin supported grafts, we therefore
hypothesize that in the process of fibrin degradation the
inflammatory response with accumulation of macrophages
and excretion of a variety of cytokines and elastases leads
to lysis of elastin fibers. This could explain aneurysmal
degeneration and intense accumulation of neointimal
hyperplasia because in a distorted vessel architecture blood
flow cannot be expected to be laminar, and vessel wall
shear stress is likely to be greater and not predictable,
leading to higher adaptive responses of the vessel and to
excessive neointimal formation.
We conclude that in our hands external support of vein
grafts by application of fibrin glue does not prevent neointimal
hyperplasia in the long term, but, on the contrary, leads to an
intense neointimal hyperplasia possibly due to the inflamma-
tory response leading to cellular proliferation (smooth muscle
cells [SMC], myofibroblasts), cell migration (SMC from the
media, myofibroblasts from the periadventitia, macrophages
from luminal and adventitial side, platelets from luminal side),
extracellular matrix deposition, and inflammatory processes
(leukocytes, platelets, growth factors, cytokines). Disrupted
elastin fibers within the vein vessel wall in fibrin control veins
add data to the possible detrimental effect of fibrin. This could
possibly be a factor, which contributes to long-term vein graft
failure. Our data raise the question whether the possible
detrimental effects of local fibrin application on vein grafts
contradict the theoretical advantages of drug delivery through




Fig. 4 A Histological section stained by Elastica van Giesson of a
fibrin glue externally supported vein graft showing a widespread loss
of elastic fibers within the vessel wall (×100 magnification) B
Histological section stained by Elastica van Giesson of an unsupport-
ed control graft showing preserved elastic fibers within the vessel wall
(×100 magnification) C Histological section stained by Elastica van
Giesson of a fibrin control graft showing disrupted elastic fibers
within the vessel wall and some degree of inflammation (×100
magnification)
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by clinical observations showing an unfavorable risk—benefit
relation for the intraoperative use of fibrin glue [16, 17]
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